Mesa Laboratories (NASDAQ:MLAB) Stock Price Crosses Above Two Hundred Day Moving Average of $100.36

Mesa Laboratories, Inc. (NASDAQ:MLAB) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $100.36 and traded as high as $117.11. Mesa Laboratories shares last traded at $117.11, with a volume of 30,239 shares.

Wall Street Analysts Forecast Growth

Separately, Evercore ISI upped their price objective on Mesa Laboratories from $124.00 to $130.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th.

Mesa Laboratories Stock Performance

The company has a current ratio of 2.68, a quick ratio of 1.86 and a debt-to-equity ratio of 0.58. The company’s 50-day moving average is $106.29 and its two-hundred day moving average is $100.36. The stock has a market capitalization of $631.69 million, a P/E ratio of 688.88 and a beta of 0.82.

Mesa Laboratories (NASDAQ:MLAB) last released its quarterly earnings results on Monday, February 5th. The medical instruments supplier reported $1.46 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.01). The business had revenue of $53.47 million for the quarter, compared to the consensus estimate of $54.90 million. Mesa Laboratories had a net margin of 0.45% and a return on equity of 7.41%. As a group, sell-side analysts anticipate that Mesa Laboratories, Inc. will post 6.15 EPS for the current fiscal year.

Mesa Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Friday, May 31st will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.55%. The ex-dividend date is Friday, May 31st. Mesa Laboratories’s payout ratio is currently 376.47%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Quadrant Capital Group LLC lifted its holdings in Mesa Laboratories by 515.6% in the fourth quarter. Quadrant Capital Group LLC now owns 277 shares of the medical instruments supplier’s stock worth $29,000 after purchasing an additional 232 shares during the period. Louisiana State Employees Retirement System acquired a new stake in shares of Mesa Laboratories in the 4th quarter worth approximately $272,000. SG Americas Securities LLC boosted its holdings in shares of Mesa Laboratories by 23.1% in the third quarter. SG Americas Securities LLC now owns 2,928 shares of the medical instruments supplier’s stock valued at $308,000 after acquiring an additional 549 shares in the last quarter. Illinois Municipal Retirement Fund acquired a new position in shares of Mesa Laboratories during the third quarter valued at approximately $341,000. Finally, Jump Financial LLC raised its holdings in Mesa Laboratories by 77.4% during the third quarter. Jump Financial LLC now owns 3,293 shares of the medical instruments supplier’s stock worth $346,000 after purchasing an additional 1,437 shares in the last quarter. Institutional investors own 90.60% of the company’s stock.

About Mesa Laboratories

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.